Literature DB >> 26297874

Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses.

Sarah L Sheridan1, Robert S Ware2, Keith Grimwood3, Stephen B Lambert4.   

Abstract

Several observational studies provide evidence that acellular pertussis vaccines (aP) are less protective against pertussis disease than highly effective whole-cell pertussis vaccines (wP), however, concerns have been raised that some of these findings may be confounded by age. By undertaking age-stratified and restricted analyses on a cohort of Australian children primed with either aP-only, wP-only or mixed pertussis vaccine schedules, we demonstrate that compared to aP the association of wP with increased protection from pertussis is not confounded by age, nor by aP booster-dose receipt.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acellular pertussis vaccine; Confounding; Pertussis; Vaccine effectiveness; Whole-cell pertussis vaccine

Mesh:

Substances:

Year:  2015        PMID: 26297874     DOI: 10.1016/j.vaccine.2015.08.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study.

Authors:  Breanna Barger-Kamate; Maria Deloria Knoll; E Wangeci Kagucia; Christine Prosperi; Henry C Baggett; W Abdullah Brooks; Daniel R Feikin; Laura L Hammitt; Stephen R C Howie; Orin S Levine; Shabir A Madhi; J Anthony G Scott; Donald M Thea; Tussanee Amornintapichet; Trevor P Anderson; Juliet O Awori; Vicky L Baillie; James Chipeta; Andrea N DeLuca; Amanda J Driscoll; Doli Goswami; Melissa M Higdon; Lokman Hossain; Ruth A Karron; Susan Maloney; David P Moore; Susan C Morpeth; Lawrence Mwananyanda; Ogochukwu Ofordile; Emmanuel Olutunde; Daniel E Park; Samba O Sow; Milagritos D Tapia; David R Murdoch; Katherine L O'Brien; Karen L Kotloff
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

2.  Does the economic recession influence the incidence of pertussis in a cosmopolitan European city?

Authors:  Sílvia Brugueras; Cristina Rius; Joan-Pau Millet; Martí Casals; Joan A Caylà
Journal:  BMC Public Health       Date:  2019-02-04       Impact factor: 3.295

3.  The prevalence and clinical characteristics of pertussis-associated pneumonia among infants in Botswana.

Authors:  Bahaa Abu-Raya; David M Goldfarb; Marek Smieja; Kathy Luinstra; Melissa Richard-Greenblatt; Andrew P Steenhoff; Kristen A Feemster; Tonya Arscott-Mills; Coleen K Cunningham; Samir S Shah; Mohamed Zaakir Patel; Matthew S Kelly; Manish Sadarangani
Journal:  BMC Pediatr       Date:  2019-11-16       Impact factor: 2.125

4.  Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.

Authors:  Ulrich Heininger; Philippe André; Roman Chlibek; Zuzana Kristufkova; Kuulo Kutsar; Atanas Mangarov; Zsófia Mészner; Aneta Nitsch-Osuch; Vladimir Petrović; Roman Prymula; Vytautas Usonis; Dace Zavadska
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

5.  Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

Authors:  Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

6.  Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.

Authors:  Pedro A Reche
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.